Staurosporine [62996-74-1]

Cat# HY-15141-10mg

Size : 10mg

Brand : MedChemExpress

Request more information

Contact local distributor :


Phone : +1 850 650 7790

Description

Staurosporine is a potent, ATP-competitive and non-selective inhibitor of protein kinases with IC50s of 6 nM, 15 nM, 2 nM, and 3 nM for PKC, PKA, c-Fgr, and Phosphorylase kinase respectively. Staurosporine also inhibits TAOK2 with an IC50 of 3 μM. Staurosporine is an apoptosis inducer[1][2][3][4][5].

IC50 & Target[1]

PKC

6 nM (IC50)

PKA

15 nM (IC50)

c-Fgr

2 nM (IC50)

Phosphorylase kinase

3 nM (IC50)

S6 kinase (70 kDa)

5 nM (IC50)

v-Src

6 nM (IC50)

cdc2

9 nM (IC50)

TPK-IIB/Syk

16 nM (IC50)

Ca2+/CaM PK-I1

20 nM (IC50)

MLCK

21 nM (IC50)

IR

61 nM (IC50)

EGF-R

100 nM (IC50)

ERK-1

1500 nM (IC50)

CSK

2000 nM (IC50)

IGF-IR

6150 nM (IC50)

CK2

19500 nM (IC50)

CK1

163500 nM (IC50)

Cellular Effect
Cell Line Type Value Description References
518A2 EC50
0.03 μM
Compound: STS
Cytotoxicity against human 518A2 cells after 96 hrs by SRB assay
Cytotoxicity against human 518A2 cells after 96 hrs by SRB assay
[PMID: 29197730]
518A2 IC50
0.2 μM
Compound: STP
Cytotoxicity against human 518A2 cells after 96 hrs by SRB assay
Cytotoxicity against human 518A2 cells after 96 hrs by SRB assay
[PMID: 24361521]
8505C IC50
0.2 μM
Compound: STP
Cytotoxicity against human 8505C cells after 96 hrs by SRB assay
Cytotoxicity against human 8505C cells after 96 hrs by SRB assay
[PMID: 24361521]
A2780 EC50
0.1 μM
Compound: Staurosporine
Cytotoxicity against human A2780 cells assessed as reduction in cell viability measured after 72 hrs by SRB assay
Cytotoxicity against human A2780 cells assessed as reduction in cell viability measured after 72 hrs by SRB assay
[PMID: 33049606]
A2780 IC50
0.1 μM
Compound: ST
Cytotoxicity against human A2780 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
Cytotoxicity against human A2780 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
[PMID: 32422522]
A2780 EC50
0.1 μM
Compound: STS
Cytotoxicity against human A2780 cells assessed as reduction in cell viability after 96 hrs by SRB assay
Cytotoxicity against human A2780 cells assessed as reduction in cell viability after 96 hrs by SRB assay
[PMID: 30840925]
A2780 EC50
0.12 μM
Compound: STS
Cytotoxicity against human A2780 cells after 96 hrs by SRB assay
Cytotoxicity against human A2780 cells after 96 hrs by SRB assay
[PMID: 29197730]
A2780 IC50
0.2 μM
Compound: STP
Cytotoxicity against human A2780 cells after 96 hrs by SRB assay
Cytotoxicity against human A2780 cells after 96 hrs by SRB assay
[PMID: 24361521]
A-375 IC50
2.1 μM
Compound: Staurosporine
Antiproliferative activity against human A-375 cells assessed as reduction in cell viability measured after 48 hrs by colorimetric based MTT assay
Antiproliferative activity against human A-375 cells assessed as reduction in cell viability measured after 48 hrs by colorimetric based MTT assay
[PMID: 35196017]
A-431 IC50
70 nM
Compound: Staurosporine
Cytotoxicity against human A431 cells after 24 hrs using Annexin VeFITC/propidium iodide staining by MTT assay
Cytotoxicity against human A431 cells after 24 hrs using Annexin VeFITC/propidium iodide staining by MTT assay
[PMID: 22541051]
A549 IC50
0.02 μM
Compound: staurosporine
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
[PMID: 25825934]
A549 IC50
0.02 μM
Compound: Staurosporine
Cytotoxicity against human A549 cells assessed as growth inhibition after 48 hrs by MTT assay
Cytotoxicity against human A549 cells assessed as growth inhibition after 48 hrs by MTT assay
10.1039/C2MD20098H
A549 EC50
0.04 μM
Compound: STS
Cytotoxicity against human A549 cells after 96 hrs by SRB assay
Cytotoxicity against human A549 cells after 96 hrs by SRB assay
[PMID: 29197730]
A549 IC50
0.6 μM
Compound: STP
Cytotoxicity against human A549 cells after 96 hrs by SRB assay
Cytotoxicity against human A549 cells after 96 hrs by SRB assay
[PMID: 24361521]
A549 IC50
13.22 μM
Compound: Staurosporine
Antiproliferative activity against human A549 cells measured after 72 hrs under CoCl2-induced hypoxic condition by MTT assay
Antiproliferative activity against human A549 cells measured after 72 hrs under CoCl2-induced hypoxic condition by MTT assay
[PMID: 31794211]
A549 IC50
139.95 ng/mL
Compound: Staurosporine
Cytotoxicity against human A549 cells after 24 hrs by YO-PRO-1 assay
Cytotoxicity against human A549 cells after 24 hrs by YO-PRO-1 assay
[PMID: 19138858]
A549 IC50
139.95 ng/mL
Compound: Staurosporine
Cytotoxicity against human A549 cells after 24 hrs by propidium iodide assay
Cytotoxicity against human A549 cells after 24 hrs by propidium iodide assay
[PMID: 19138858]
A549 GI50
2.4 nM
Compound: staurosporine
Cytotoxicity against human A549 cells after 72 hrs by sulforhodamine B method
Cytotoxicity against human A549 cells after 72 hrs by sulforhodamine B method
[PMID: 18484775]
A549 IC50
3.05 μM
Compound: Staurosporine
Antiproliferative activity against human A549 cells after 24 to 48 hrs by CCK-8 assay
Antiproliferative activity against human A549 cells after 24 to 48 hrs by CCK-8 assay
[PMID: 24792811]
A549 IC50
7.47 μM
Compound: Staurosporine
Antiproliferative activity against human A549 cells measured after 72 hrs under normoxic condition by MTT assay
Antiproliferative activity against human A549 cells measured after 72 hrs under normoxic condition by MTT assay
[PMID: 31794211]
A549 IC50
9.1 μM
Compound: Staurosporine
Antiproliferative activity against human A549 cells assessed as reduction in cell viability measured after 48 hrs by colorimetric based MTT assay
Antiproliferative activity against human A549 cells assessed as reduction in cell viability measured after 48 hrs by colorimetric based MTT assay
[PMID: 35196017]
A549 IC50
9.5 μM
Compound: Staurosporine
Cytotoxicity against human A549 cells assessed as cell viability measured by MTT assay
Cytotoxicity against human A549 cells assessed as cell viability measured by MTT assay
[PMID: 34246754]
B16-F10 IC50
2.82 μM
Compound: Staurosporine
Antiproliferative activity against mouse B16F10 cells after 48 hrs by MTT assay
Antiproliferative activity against mouse B16F10 cells after 48 hrs by MTT assay
[PMID: 22503364]
BGC-823 IC50
0.38 μM
Compound: Staurosporine
Cytotoxicity against human BGC823 cells after 72 hrs by CellTitre-Glo luminescent cell viability assay
Cytotoxicity against human BGC823 cells after 72 hrs by CellTitre-Glo luminescent cell viability assay
[PMID: 24328283]
BGC-823 EC50
26.83 μg/mL
Compound: Staurosporine
Antiproliferative activity against human BGC823 cells after 48 hrs by MTT assay
Antiproliferative activity against human BGC823 cells after 48 hrs by MTT assay
[PMID: 21889345]
BGC-823 IC50
6.83 μM
Compound: Staurosporine
Antiproliferative activity against human BGC823 cells after 48 hrs by MTT method
Antiproliferative activity against human BGC823 cells after 48 hrs by MTT method
[PMID: 23018096]
BJ EC50
> 40 μM
Compound: STS
Antiproliferative activity against human BJ cells after 72 hrs by CellTiter-Glo luminescent cell viability assay
Antiproliferative activity against human BJ cells after 72 hrs by CellTiter-Glo luminescent cell viability assay
[PMID: 30840453]
BJ IC50
0.002 μM
Compound: Staurosporine
Cytotoxicity against human BJ cells after 72 hrs by Calcein AM assay
Cytotoxicity against human BJ cells after 72 hrs by Calcein AM assay
[PMID: 22921081]
BT-549 IC50
0.08 μM
Compound: Staurosporine
Cytotoxic activity against human BT549 cells incubated for 24 hrs by MTT assay
Cytotoxic activity against human BT549 cells incubated for 24 hrs by MTT assay
[PMID: 28705432]
CAPAN-1 IC50
0.0123 μM
Compound: Staurosporine
Antiproliferative activity against human CAPAN-1 cells assessed as inhibition of cell proliferation measured after 72 hrs by by real time imaging analysis
Antiproliferative activity against human CAPAN-1 cells assessed as inhibition of cell proliferation measured after 72 hrs by by real time imaging analysis
[PMID: 33248847]
CAPAN-1 IC50
0.03 μM
Compound: STS
Antiproliferative activity against human Capan1 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell imaging assay
Antiproliferative activity against human Capan1 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell imaging assay
[PMID: 32832030]
CAPAN-1 IC50
0.0546 μM
Compound: Staurosporine
Antiproliferative activity against human CAPAN-1 cells assessed as inhibition of cell viability measured after 72 hrs by colorimetric MTS viability assay
Antiproliferative activity against human CAPAN-1 cells assessed as inhibition of cell viability measured after 72 hrs by colorimetric MTS viability assay
[PMID: 34352711]
Ca-Ski IC50
0.01144 μM
Compound: Staurosporine
Antiproliferative activity against human Ca-Ski cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter-Glo luminescent cell viability assay
Antiproliferative activity against human Ca-Ski cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter-Glo luminescent cell viability assay
[PMID: 34656041]
CCRF-CEM IC50
0.023 μM
Compound: Staurosporine
Cytotoxicity against human CEM cells after 72 hrs by Calcein AM assay
Cytotoxicity against human CEM cells after 72 hrs by Calcein AM assay
[PMID: 22921081]
CHO-K1 GI50
0.13 μM
Compound: Staurosporine
Cytotoxicity against human CHOK1 cells after 48 hrs by SRB assay
Cytotoxicity against human CHOK1 cells after 48 hrs by SRB assay
[PMID: 21513294]
COLO 205 IC50
< 0.1 μM
Compound: Staurosporine
Antiproliferative activity against human COLO205 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
Antiproliferative activity against human COLO205 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
[PMID: 31740249]
DLD-1 IC50
0.009 μM
Compound: Staurosporine
Antiproliferative activity against human DLD1 cells after 48 to 72 hrs by MTT assay
Antiproliferative activity against human DLD1 cells after 48 to 72 hrs by MTT assay
[PMID: 22182929]
DLD-1 IC50
0.009 μM
Compound: Staurosporine
Antiproliferative activity against human colon cancer cell line (DLD-1 cells) using MTT assay
Antiproliferative activity against human colon cancer cell line (DLD-1 cells) using MTT assay
[PMID: 11591505]
DU-145 IC50
0.5 μM
Compound: Staurosporine
Induction of mitochondrial membrane potential loss in human DU145 cells after 2 hrs by JC1 staining based fluorescence assay
Induction of mitochondrial membrane potential loss in human DU145 cells after 2 hrs by JC1 staining based fluorescence assay
[PMID: 31120251]
FaDu EC50
0.1 μM
Compound: Staurosporine
Cytotoxicity against human FaDu cells assessed as reduction in cell viability measured after 72 hrs by SRB assay
Cytotoxicity against human FaDu cells assessed as reduction in cell viability measured after 72 hrs by SRB assay
[PMID: 33049606]
FaDu IC50
0.1 μM
Compound: ST
Cytotoxicity against human FaDu cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
Cytotoxicity against human FaDu cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
[PMID: 32422522]
FaDu EC50
0.2 μM
Compound: STS
Cytotoxicity against human FADU cells assessed as reduction in cell viability after 96 hrs by SRB assay
Cytotoxicity against human FADU cells assessed as reduction in cell viability after 96 hrs by SRB assay
[PMID: 30840925]
HaCaT IC50
1.6 μM
Compound: Staurosporine
Antiproliferative activity against human HaCaT cells assessed as reduction in cell viability measured after 48 hrs by colorimetric based MTT assay
Antiproliferative activity against human HaCaT cells assessed as reduction in cell viability measured after 48 hrs by colorimetric based MTT assay
[PMID: 35196017]
HCT-116 IC50
< 0.1 μM
Compound: Staurosporine
Antiproliferative activity against human HCT116 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
Antiproliferative activity against human HCT116 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
[PMID: 31740249]
HCT-116 IC50
0.0281 μM
Compound: Staurosporine
Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell proliferation measured after 72 hrs by by real time imaging analysis
Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell proliferation measured after 72 hrs by by real time imaging analysis
[PMID: 33248847]
HCT-116 IC50
0.03 μM
Compound: Staurosporine
Cytotoxicity against human HCT116 cells assessed as decrease in cell viability after 48 hrs by MTT assay
Cytotoxicity against human HCT116 cells assessed as decrease in cell viability after 48 hrs by MTT assay
[PMID: 30106291]
HCT-116 IC50
0.04 μM
Compound: STS
Antiproliferative activity against human HCT116 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell imaging assay
Antiproliferative activity against human HCT116 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell imaging assay
[PMID: 32832030]
HCT-116 IC50
0.0481 μM
Compound: Staurosporine
Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell viability measured after 72 hrs by colorimetric MTS viability assay
Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell viability measured after 72 hrs by colorimetric MTS viability assay
[PMID: 34352711]
HCT-116 IC50
0.055 μM
Compound: Staurosporine
Cytotoxicity against human HCT116 cells by sulforhodamine B assay
Cytotoxicity against human HCT116 cells by sulforhodamine B assay
[PMID: 29389122]
HCT-116 IC50
13.2 μM
Compound: Staurosporine
Antiproliferative activity against Homo sapiens (human) HCT116 cells assessed as growth inhibition after 48 hr by MTT assay
Antiproliferative activity against Homo sapiens (human) HCT116 cells assessed as growth inhibition after 48 hr by MTT assay
10.1007/s00044-012-0306-5
HCT-116 IC50
16.15 μM
Compound: Staurosporine
Antiproliferative activity against human HCT116 cells measured after 72 hrs under CoCl2-induced hypoxic condition by MTT assay
Antiproliferative activity against human HCT116 cells measured after 72 hrs under CoCl2-induced hypoxic condition by MTT assay
[PMID: 31794211]
HCT-116 IC50
39 nM
Compound: Staurosporine
Inhibition of TNIK-mediated TCF4/beta-casein transcription in human HCT116 cells by beta-lactamase reporter gene assay
Inhibition of TNIK-mediated TCF4/beta-casein transcription in human HCT116 cells by beta-lactamase reporter gene assay
[PMID: 23232060]
HCT-116 IC50
6.94 μM
Compound: Staurosporine
Anticancer activity against human HCT-116 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay
Anticancer activity against human HCT-116 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay
[PMID: 35694689]
HCT-116 IC50
8.86 μM
Compound: Staurosporine
Antiproliferative activity against human HCT116 cells measured after 72 hrs under normoxic condition by MTT assay
Antiproliferative activity against human HCT116 cells measured after 72 hrs under normoxic condition by MTT assay
[PMID: 31794211]
HEK293 CC50
0.00354 μM
Compound: Staurosporine
Cytotoxicity against HEK293 cells assessed as decrease in cell viability after 72 hrs by CellTiter Glo luminescent assay
Cytotoxicity against HEK293 cells assessed as decrease in cell viability after 72 hrs by CellTiter Glo luminescent assay
[PMID: 28624701]
HEK293 IC50
0.0037 μM
Compound: Staurosporine
Cytotoxicity against human HEK293 cells assessed as cell viability incubated for 72 hrs by cell titer-glo luminescent cell viability assay (Rvb = > 100 uM)
Cytotoxicity against human HEK293 cells assessed as cell viability incubated for 72 hrs by cell titer-glo luminescent cell viability assay (Rvb = > 100 uM)
[PMID: 31252285]
HEK293 IC50
0.056 μM
Compound: Staurosporine
Cytotoxicity against HEK293 cells after 72 hrs by CellTiterGlo assay
Cytotoxicity against HEK293 cells after 72 hrs by CellTiterGlo assay
[PMID: 24763262]
HEK293 IC50
0.077 μM
Compound: staurosporine
Inhibition of PKC-beta II mediated IL-8 release from HEK293 cells by ELISA
Inhibition of PKC-beta II mediated IL-8 release from HEK293 cells by ELISA
[PMID: 12941331]
HEK293 IC50
0.077 μM
Compound: Staurosporine
Inhibition of IL-8 release by HEK293 cells expressing PKC-beta2
Inhibition of IL-8 release by HEK293 cells expressing PKC-beta2
[PMID: 15771419]
HEK293 IC50
0.41 μM
Compound: Staurosporine
Antiproliferative activity against HEK293 cells assessed as inhibition rate incubated for 72 hrs by MTT assay
Antiproliferative activity against HEK293 cells assessed as inhibition rate incubated for 72 hrs by MTT assay
[PMID: 34844412]
HEK293 IC50
34.33 μM
Compound: Staurosporine
Cytotoxicity against human HEK293 cells assessed as inhibition of cell viability by MTT assay
Cytotoxicity against human HEK293 cells assessed as inhibition of cell viability by MTT assay
[PMID: 35182815]
HeLa IC50
0.025 μM
Compound: staurosporine
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
[PMID: 25825934]
HeLa IC50
0.025 μM
Compound: Staurosporine
Cytotoxicity against human HeLa cells assessed as growth inhibition after 48 hrs by MTT assay
Cytotoxicity against human HeLa cells assessed as growth inhibition after 48 hrs by MTT assay
10.1039/C2MD20098H
HeLa IC50
0.175 μM
Compound: Staurosporine
Cytotoxicity against human HeLa cells after 72 hrs by Calcein AM assay
Cytotoxicity against human HeLa cells after 72 hrs by Calcein AM assay
[PMID: 22921081]
HeLa IC50
2.72 μM
Compound: Staurosporine
Antiproliferative activity against human HeLa cells after 24 to 48 hrs by CCK-8 assay
Antiproliferative activity against human HeLa cells after 24 to 48 hrs by CCK-8 assay
[PMID: 24792811]
HeLa EC50
29.12 μg/mL
Compound: Staurosporine
Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay
Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay
[PMID: 21889345]
HeLa IC50
4 pM
Compound: Staurosporine
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
[PMID: 21488655]
HeLa IC50
4 pM
Compound: Staurosporine
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
[PMID: 21388191]
HeLa IC50
9.12 μM
Compound: Staurosporine
Antiproliferative activity against human HeLa cells after 48 hrs by MTT method
Antiproliferative activity against human HeLa cells after 48 hrs by MTT method
[PMID: 23018096]
HeLa S3 IC50
4 pM
Compound: Staurosporine
Cytotoxicity against human HeLa S3 cells measured after 72 hrs
Cytotoxicity against human HeLa S3 cells measured after 72 hrs
[PMID: 32688198]
HepG2 IC50
0.018 μM
Compound: Staurosporine
Cytotoxicity against human HepG2 cells at 100 uM after 3 days by CellTiter-Glo luminescent cell viability assay
Cytotoxicity against human HepG2 cells at 100 uM after 3 days by CellTiter-Glo luminescent cell viability assay
[PMID: 28993106]
HepG2 EC50
21.74 μg/mL
Compound: Staurosporine
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
[PMID: 21889345]
HepG2 IC50
4.14 μM
Compound: Staurosporine
Inhibition of telomerase in human HepG2 cells after 24 hrs by TRAP-PCR-ELISA assay
Inhibition of telomerase in human HepG2 cells after 24 hrs by TRAP-PCR-ELISA assay
[PMID: 23018096]
HepG2 IC50
6.73 μM
Compound: Staurosporine
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT method
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT method
[PMID: 23018096]
HepG2 IC50
8.3 μM
Compound: Staurosporine
Inhibition of telomerase in human HepG2 cells after 48 hrs by TRAP-PCR-ELISA
Inhibition of telomerase in human HepG2 cells after 48 hrs by TRAP-PCR-ELISA
[PMID: 23279864]
HepG2 IC50
9.04 μM
Compound: Staurosporine
Antiproliferative activity against Homo sapiens (human) HepG2 cells assessed as growth inhibition after 48 hr by MTT assay
Antiproliferative activity against Homo sapiens (human) HepG2 cells assessed as growth inhibition after 48 hr by MTT assay
10.1007/s00044-012-0306-5
HL-60 IC50
0.0076 μM
Compound: Staurosporine
Antiproliferative activity against human HL-60 cells assessed as inhibition of cell proliferation measured after 72 hrs by by real time imaging analysis
Antiproliferative activity against human HL-60 cells assessed as inhibition of cell proliferation measured after 72 hrs by by real time imaging analysis
[PMID: 33248847]
HL-60 IC50
0.04 μM
Compound: STS
Antiproliferative activity against human HL60 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell imaging assay
Antiproliferative activity against human HL60 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell imaging assay
[PMID: 32832030]
HL-60 IC50
0.041 μM
Compound: Staurosporine
Antiproliferative activity against human HL-60 cells assessed as inhibition of cell viability measured after 72 hrs by real-time IncuCyte proliferation analysis
Antiproliferative activity against human HL-60 cells assessed as inhibition of cell viability measured after 72 hrs by real-time IncuCyte proliferation analysis
[PMID: 34352711]
HMLE IC50
4.9 nM
Compound: 1
Cytotoxicity against human HMLE cells assessed as reduction in cell metabolic activity after 72 hrs by MTS assay
Cytotoxicity against human HMLE cells assessed as reduction in cell metabolic activity after 72 hrs by MTS assay
[PMID: 33335665]
HT-29 ED50
> 20 μM
Compound: Staurosporine
Cytotoxicity against human HT-29 cells after 3 days by sulforhodamine B assay
Cytotoxicity against human HT-29 cells after 3 days by sulforhodamine B assay
[PMID: 21973101]
HT-29 ED50
0.0026 μM
Compound: Staurosporine
Induction of apoptosis in human HT-29 cells assessed reduction of mitochondrial membrane potential after 2 hrs by using JC1 staining by fluorescence cell-based assay
Induction of apoptosis in human HT-29 cells assessed reduction of mitochondrial membrane potential after 2 hrs by using JC1 staining by fluorescence cell-based assay
[PMID: 21973101]
HT-29 EC50
0.15 μM
Compound: STS
Cytotoxicity against human HT-29 cells after 96 hrs by SRB assay
Cytotoxicity against human HT-29 cells after 96 hrs by SRB assay
[PMID: 29197730]
HT-29 EC50
0.2 μM
Compound: Staurosporine
Cytotoxicity against human HT-29 cells assessed as reduction in cell viability measured after 72 hrs by SRB assay
Cytotoxicity against human HT-29 cells assessed as reduction in cell viability measured after 72 hrs by SRB assay
[PMID: 33049606]
HT-29 IC50
0.2 μM
Compound: ST
Cytotoxicity against human HT29 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
Cytotoxicity against human HT29 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
[PMID: 32422522]
HT-29 EC50
0.2 μM
Compound: STS
Cytotoxicity against human HT-29 cells assessed as reduction in cell viability after 96 hrs by SRB assay
Cytotoxicity against human HT-29 cells assessed as reduction in cell viability after 96 hrs by SRB assay
[PMID: 30840925]
HT-29 IC50
0.2 μM
Compound: STP
Cytotoxicity against human HT-29 cells after 96 hrs by SRB assay
Cytotoxicity against human HT-29 cells after 96 hrs by SRB assay
[PMID: 24361521]
HT-29 GI50
10.9 nM
Compound: staurosporine
Cytotoxicity against human HT29 cells after 72 hrs by sulforhodamine B method
Cytotoxicity against human HT29 cells after 72 hrs by sulforhodamine B method
[PMID: 18484775]
HT-29 IC50
2 nM
Compound: Staurosporine
Effect on mitochondrial membrane potential in human HT-29 cells after 2 hrs using JC-1 staining by fluorescence assay
Effect on mitochondrial membrane potential in human HT-29 cells after 2 hrs using JC-1 staining by fluorescence assay
[PMID: 21428375]
HT-29 IC50
2.5 nM
Compound: Staurosporine
Inhibition of mitochondrial membrane potential in human HT-29 cells using JC1 dye staining by fluorescence plate reader assay
Inhibition of mitochondrial membrane potential in human HT-29 cells using JC1 dye staining by fluorescence plate reader assay
[PMID: 21513293]
HT-29 ED50
2.6 nM
Compound: staurosporine
Induction of apoptosis in human HT-29 cells assessed as change in mitochondrial transmembrane potential after 2 hrs by JC1 staining based fluorescence assay
Induction of apoptosis in human HT-29 cells assessed as change in mitochondrial transmembrane potential after 2 hrs by JC1 staining based fluorescence assay
[PMID: 19422206]
HT-29 IC50
20 nM
Compound: Staurosporine
Inhibition of mitochondrial membrane potential in human HT-29 cells after 3 hrs by JC-1 staining based fluorescence assay
Inhibition of mitochondrial membrane potential in human HT-29 cells after 3 hrs by JC-1 staining based fluorescence assay
[PMID: 30057155]
HT-29 GI50
3.6 μM
Compound: Staurosporine
Cytotoxicity against human HT-29 cells after 48 hrs by SRB assay
Cytotoxicity against human HT-29 cells after 48 hrs by SRB assay
[PMID: 21513294]
Huh-7 IC50
0.23 μM
Compound: Staurosporine
Cytotoxicity against human HuH7 cells after 72 hrs by CellTitre-Glo luminescent cell viability assay
Cytotoxicity against human HuH7 cells after 72 hrs by CellTitre-Glo luminescent cell viability assay
[PMID: 24328283]
HUVEC IC50
0.004 μM
Compound: Staurosporine
Antiproliferative activity against human HUVEC after 48 to 72 hrs by MTT assay
Antiproliferative activity against human HUVEC after 48 to 72 hrs by MTT assay
[PMID: 22182929]
HUVEC IC50
0.004 μM
Compound: Staurosporine
Antiproliferative activity against human umbilical vein endothelial cells (HUVECs) using MTT assay
Antiproliferative activity against human umbilical vein endothelial cells (HUVECs) using MTT assay
[PMID: 11591505]
HUVEC IC50
0.5 μM
Compound: STS
Cytotoxicity against HUVEC cells assessed as reduction in cell viability after 96 hrs by MTT assay
Cytotoxicity against HUVEC cells assessed as reduction in cell viability after 96 hrs by MTT assay
[PMID: 34671737]
Jurkat IC50
0.0393 μM
Compound: Staurosporine
Cytotoxicity against human Jurkat cells assessed as inhibition of cell viability measured after 72 hrs by real-time IncuCyte proliferation analysis
Cytotoxicity against human Jurkat cells assessed as inhibition of cell viability measured after 72 hrs by real-time IncuCyte proliferation analysis
[PMID: 34352711]
Jurkat IC50
0.14 μM
Compound: Staurosporine
Cytotoxicity against human Jurkat cells after 72 hrs by CellTitre-Glo luminescent cell viability assay
Cytotoxicity against human Jurkat cells after 72 hrs by CellTitre-Glo luminescent cell viability assay
[PMID: 24328283]
Jurkat IC50
3.2 μM
Compound: Staurosporine
Antiproliferative activity against human Jurkat cells assessed as reduction in cell viability measured after 48 hrs by colorimetric based MTT assay
Antiproliferative activity against human Jurkat cells assessed as reduction in cell viability measured after 48 hrs by colorimetric based MTT assay
[PMID: 35196017]
K562 IC50
> 0.1 μM
Compound: Staurosporine
Antiproliferative activity against human K562 cells assessed as inhibition of cell viability measured after 72 hrs by real-time IncuCyte proliferation analysis
Antiproliferative activity against human K562 cells assessed as inhibition of cell viability measured after 72 hrs by real-time IncuCyte proliferation analysis
[PMID: 34352711]
K562 IC50
0.04 μM
Compound: STS
Antiproliferative activity against human K562 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell imaging assay
Antiproliferative activity against human K562 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell imaging assay
[PMID: 32832030]
K562 IC50
0.0768 μM
Compound: Staurosporine
Antiproliferative activity against human K562 cells assessed as inhibition of cell proliferation measured after 72 hrs by by real time imaging analysis
Antiproliferative activity against human K562 cells assessed as inhibition of cell proliferation measured after 72 hrs by by real time imaging analysis
[PMID: 33248847]
K562 IC50
1.7 μM
Compound: Staurosporine
Cytotoxicity against human K562 cells assessed as decrease in cell viability after 48 hrs by MTT assay
Cytotoxicity against human K562 cells assessed as decrease in cell viability after 48 hrs by MTT assay
[PMID: 30106291]
K562 IC50
153 μM
Compound: STSP
Antitumor activity against human K562 cells assessed as inhibition of cell growth after 48 hrs by MTT assay
Antitumor activity against human K562 cells assessed as inhibition of cell growth after 48 hrs by MTT assay
[PMID: 26022079]
KB 3-1 IC50
< 0.2 μM
Compound: Staurosporine
Antiproliferative activity against human KB-3-1 cells after 5 days by WST-1 assay
Antiproliferative activity against human KB-3-1 cells after 5 days by WST-1 assay
[PMID: 28956915]
KOPN-8 EC50
0.71 μM
Compound: STS
Antiproliferative activity against human KOPN8 cells after 72 hrs by CellTiter-Glo luminescent cell viability assay
Antiproliferative activity against human KOPN8 cells after 72 hrs by CellTiter-Glo luminescent cell viability assay
[PMID: 30840453]
L02 IC50
9.5 μM
Compound: Staurosporine
Cytotoxicity against human LO2 cells assessed as decrease in cell viability after 48 hrs by MTT assay
Cytotoxicity against human LO2 cells assessed as decrease in cell viability after 48 hrs by MTT assay
[PMID: 30106291]
L929 IC50
< 0.2 μM
Compound: Staurosporine
Antiproliferative activity against mouse L929 cells after 5 days by WST-1 assay
Antiproliferative activity against mouse L929 cells after 5 days by WST-1 assay
[PMID: 28956915]
Leukemia cell EC50
0.35 μM
Compound: STS
Antiproliferative activity against mouse leukemia cells overexpressing BCR/ABL after 72 hrs by CellTiter-Glo luminescent cell viability assay
Antiproliferative activity against mouse leukemia cells overexpressing BCR/ABL after 72 hrs by CellTiter-Glo luminescent cell viability assay
[PMID: 30840453]
LN-229 IC50
0.003 μM
Compound: STS
Antiproliferative activity against human LN229 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell imaging assay
Antiproliferative activity against human LN229 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell imaging assay
[PMID: 32832030]
LN-229 IC50
0.0097 μM
Compound: Staurosporine
Antiproliferative activity against human LN-229 cells assessed as inhibition of cell viability measured after 72 hrs by colorimetric MTS viability assay
Antiproliferative activity against human LN-229 cells assessed as inhibition of cell viability measured after 72 hrs by colorimetric MTS viability assay
[PMID: 34352711]
LoVo IC50
0.001 μM
Compound: Staurosporine
Antiproliferative activity against human LoVo cells after 48 to 72 hrs by MTT assay
Antiproliferative activity against human LoVo cells after 48 to 72 hrs by MTT assay
[PMID: 22182929]
LoVo IC50
0.001 μM
Compound: Staurosporine
Antiproliferative activity against human colon cancer cell line (LoVo cells) using MTT assay
Antiproliferative activity against human colon cancer cell line (LoVo cells) using MTT assay
[PMID: 11591505]
LOX IMVI IC50
7.15 μM
Compound: Staurosporine
Cytotoxicity against human LOX IMVI cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay
Cytotoxicity against human LOX IMVI cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay
[PMID: 33601311]
MCF7 IC50
0.013 μM
Compound: Staurosporine
Cytotoxicity against human MCF7 cells assessed as growth inhibition after 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as growth inhibition after 48 hrs by MTT assay
10.1039/C2MD20098H
MCF7 IC50
0.064 μM
Compound: Staurosporine
Cytotoxicity against human MCF7 cells after 72 hrs by Calcein AM assay
Cytotoxicity against human MCF7 cells after 72 hrs by Calcein AM assay
[PMID: 22921081]
MCF7 EC50
0.1 μM
Compound: Staurosporine
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability measured after 72 hrs by SRB assay
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability measured after 72 hrs by SRB assay
[PMID: 33049606]
MCF7 IC50
0.1 μM
Compound: ST
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
[PMID: 32422522]
MCF7 EC50
0.1 μM
Compound: STS
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 96 hrs by SRB assay
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 96 hrs by SRB assay
[PMID: 30840925]
MCF7 EC50
0.1 μM
Compound: STS
Cytotoxicity against human MCF7 cells after 96 hrs by SRB assay
Cytotoxicity against human MCF7 cells after 96 hrs by SRB assay
[PMID: 29197730]
MCF7 IC50
0.33 μM
Compound: Staurosporine
Inhibition of VEGFR2 in human MCF7 cells by horseradish peroxidase-coupled TMB substrate based ELISA
Inhibition of VEGFR2 in human MCF7 cells by horseradish peroxidase-coupled TMB substrate based ELISA
[PMID: 31992477]
MCF7 IC50
0.4 μM
Compound: STP
Cytotoxicity against human MCF7 cells after 96 hrs by SRB assay
Cytotoxicity against human MCF7 cells after 96 hrs by SRB assay
[PMID: 24361521]
MCF7 IC50
0.52 μM
Compound: Staurosporine
Cytotoxicity against human MCF7 cells after 72 hrs by CellTitre-Glo luminescent cell viability assay
Cytotoxicity against human MCF7 cells after 72 hrs by CellTitre-Glo luminescent cell viability assay
[PMID: 24328283]
MCF7 IC50
1.8 μM
Compound: Staurosporine
Antiproliferative activity against human MCF7 cells after 5 days by WST-1 assay
Antiproliferative activity against human MCF7 cells after 5 days by WST-1 assay
[PMID: 28956915]
MCF7 GI50
11 μM
Compound: Staurosporine
Cytotoxicity against human MCF7 cells after 48 hrs by SRB assay
Cytotoxicity against human MCF7 cells after 48 hrs by SRB assay
[PMID: 21513294]
MCF7 IC50
16.06 μM
Compound: Staurosporine
Antiproliferative activity against Homo sapiens (human) MCF7 cells assessed as growth inhibition after 48 hr by MTT assay
Antiproliferative activity against Homo sapiens (human) MCF7 cells assessed as growth inhibition after 48 hr by MTT assay
10.1007/s00044-012-0306-5
MCF7 IC50
180 nM
Compound: Staurosporine
Cytotoxicity against human MCF7 cells after 24 hrs using Annexin VeFITC/propidium iodide staining by MTT assay
Cytotoxicity against human MCF7 cells after 24 hrs using Annexin VeFITC/propidium iodide staining by MTT assay
[PMID: 22541051]
MCF7 IC50
2 μM
Compound: Staurosporine
Inhibition of PKA in human MCF7 cells by array-based fluorescence assay
Inhibition of PKA in human MCF7 cells by array-based fluorescence assay
[PMID: 18656369]
MCF7 IC50
3.07 μM
Compound: Staurosporine
Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
[PMID: 22503364]
MCF7 IC50
3.39 μM
Compound: Staurosporine
Antiproliferative activity against human MCF7 cells measured after 48 hrs under normoxic condition by MTT assay
Antiproliferative activity against human MCF7 cells measured after 48 hrs under normoxic condition by MTT assay
[PMID: 31972394]
MCF7 IC50
3.67 μM
Compound: Staurosporine
Antiproliferative activity against human MCF7 cells incubated for 2 days by MTT assay
Antiproliferative activity against human MCF7 cells incubated for 2 days by MTT assay
[PMID: 33667848]
MCF7 IC50
3.67 μM
Compound: Staurosporine
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 48 hrs under normaxic condition by MTT assay
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 48 hrs under normaxic condition by MTT assay
[PMID: 32877804]
MCF7 IC50
4.1 μM
Compound: Staurosporine
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell proliferation measured after 48 hrs by MTT assay
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell proliferation measured after 48 hrs by MTT assay
[PMID: 34482273]
MCF7 IC50
4.1 μM
Compound: Staurosporine
Antiproliferative activity against human MCF7 cells assessed as cell growth inhibition measured for 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells assessed as cell growth inhibition measured for 72 hrs by MTT assay
[PMID: 34871842]
MCF7 IC50
50 nM
Compound: Staurosporine
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
[PMID: 21488655]
MCF7 IC50
50 nM
Compound: Staurosporine
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
[PMID: 21388191]
MCF7 IC50
6.08 μM
Compound: Staurosporine
Cytotoxicity against human MCF7 cells assessed as cell growth inhibition incubated for 3 days by MTT assay
Cytotoxicity against human MCF7 cells assessed as cell growth inhibition incubated for 3 days by MTT assay
[PMID: 34743062]
MCF7 IC50
6.3 μM
Compound: Staurosporine
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability measured after 48 hrs by colorimetric based MTT assay
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability measured after 48 hrs by colorimetric based MTT assay
[PMID: 35196017]
MCF7 IC50
7.25 μM
Compound: Staurosporine
Anticancer activity against human MCF7 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay
Anticancer activity against human MCF7 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay
[PMID: 35694689]
MCF7 IC50
7.33 μM
Compound: Staurosporine
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 48 hrs under chemically-induced hypoxic condition by MTT assay
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 48 hrs under chemically-induced hypoxic condition by MTT assay
[PMID: 32877804]
MCF7 IC50
8.81 μM
Compound: Staurosporine
Cytotoxicity against human MCF7 cells assessed as inhibition of cell proliferation after 3 days by MTT assay
Cytotoxicity against human MCF7 cells assessed as inhibition of cell proliferation after 3 days by MTT assay
[PMID: 31992477]
MCF7 IC50
9.2 μM
Compound: Staurosporine
Antiproliferative activity against human MCF7 cells measured after 48 hrs under CoCl2-induced hypoxic condition by MTT assay
Antiproliferative activity against human MCF7 cells measured after 48 hrs under CoCl2-induced hypoxic condition by MTT assay
[PMID: 31972394]
MDA-MB-231 IC50
0.0008581 μM
Compound: Staurosporine
Antiproliferative activity against human MDA-MB-231 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter-Glo luminescent cell viability assay
Antiproliferative activity against human MDA-MB-231 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter-Glo luminescent cell viability assay
[PMID: 34656041]
MDA-MB-231 IC50
0.01 μM
Compound: Staurosporin
Antiproliferative activity against human MDA-MB-231 cells assessed as cell viability after 24 hrs
Antiproliferative activity against human MDA-MB-231 cells assessed as cell viability after 24 hrs
[PMID: 33139111]
MDA-MB-231 IC50
0.24 μM
Compound: Staurosporine
Cytotoxic activity against human MDA-MB-231 cells incubated for 24 hrs by MTT assay
Cytotoxic activity against human MDA-MB-231 cells incubated for 24 hrs by MTT assay
[PMID: 28705432]
MDA-MB-231 IC50
2.5 nM
Compound: 1
Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell metabolic activity after 72 hrs by MTS assay
Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell metabolic activity after 72 hrs by MTS assay
[PMID: 33335665]
MDA-MB-231 IC50
4.25 μM
Compound: Staurosporine
Cytotoxicity against human MDA-MB-231 cells assessed as inhibition of cell proliferation measured after 72 hrs by SRB assay
Cytotoxicity against human MDA-MB-231 cells assessed as inhibition of cell proliferation measured after 72 hrs by SRB assay
[PMID: 32044580]
MDA-MB-231 IC50
4.31 μM
Compound: Staurosporine
Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability incubated for 48 hrs under normaxic condition by MTT assay
Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability incubated for 48 hrs under normaxic condition by MTT assay
[PMID: 32877804]
MDA-MB-231 IC50
6.75 μM
Compound: Staurosporine
Antiproliferative activity against human MDA-MB-231 cells incubated for 2 days by MTT assay
Antiproliferative activity against human MDA-MB-231 cells incubated for 2 days by MTT assay
[PMID: 33667848]
MDA-MB-231 IC50
6.75 μM
Compound: Staurosporine
Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability incubated for 48 hrs under chemically-induced hypoxic condition by MTT assay
Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability incubated for 48 hrs under chemically-induced hypoxic condition by MTT assay
[PMID: 32877804]
MDA-MB-231 GI50
7.1 nM
Compound: staurosporine
Cytotoxicity against human MDA-MB-231 cells after 72 hrs by sulforhodamine B method
Cytotoxicity against human MDA-MB-231 cells after 72 hrs by sulforhodamine B method
[PMID: 18484775]
MDA-MB-453 IC50
0.02351 μM
Compound: Staurosporine
Antiproliferative activity against human MDA-MB-453 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter-Glo luminescent cell viability assay
Antiproliferative activity against human MDA-MB-453 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter-Glo luminescent cell viability assay
[PMID: 34656041]
MDA-MB-468 IC50
0.15 μM
Compound: Staurosporine
Cytotoxic activity against human MDA-MB-468 cells incubated for 24 hrs by MTT assay
Cytotoxic activity against human MDA-MB-468 cells incubated for 24 hrs by MTT assay
[PMID: 28705432]
MDA-MB-468 IC50
4.37 μM
Compound: Staurosporine
Antiproliferative activity against human MDA-MB-468 cells measured after 48 hrs under normoxic condition by MTT assay
Antiproliferative activity against human MDA-MB-468 cells measured after 48 hrs under normoxic condition by MTT assay
[PMID: 31972394]
MDA-MB-468 IC50
6.46 μM
Compound: Staurosporine
Antiproliferative activity against human MDA-MB-468 cells measured after 48 hrs under CoCl2-induced hypoxic condition by MTT assay
Antiproliferative activity against human MDA-MB-468 cells measured after 48 hrs under CoCl2-induced hypoxic condition by MTT assay
[PMID: 31972394]
MGC-803 IC50
8.97 μM
Compound: Staurosporine
Inhibition of telomerase in human MGC-803 cells after 24 hrs by TRAP-PCR-ELISA assay
Inhibition of telomerase in human MGC-803 cells after 24 hrs by TRAP-PCR-ELISA assay
[PMID: 26900656]
MIA PaCa-2 IC50
370 nM
Compound: Staurosporine
Antiproliferative activity against MiaPaCa-2 cells by MTT assay
Antiproliferative activity against MiaPaCa-2 cells by MTT assay
[PMID: 16403626]
MM1.S IC50
0.0442 μM
Compound: Staurosporine
Antiproliferative activity against human MM1.S cells assessed as inhibition of cell proliferation measured after 72 hrs by by real time imaging analysis
Antiproliferative activity against human MM1.S cells assessed as inhibition of cell proliferation measured after 72 hrs by by real time imaging analysis
[PMID: 33248847]
MV4-11 IC50
0.05 μM
Compound: Staurosporine
Cytotoxicity against human MV4-11cells assessed as inhibition of cell viability measured after 72 hrs by real-time IncuCyte proliferation analysis
Cytotoxicity against human MV4-11cells assessed as inhibition of cell viability measured after 72 hrs by real-time IncuCyte proliferation analysis
[PMID: 34352711]
N2a IC50
0.0113 μM
Compound: Staurosporine
Cytotoxicity against mouse Neuro2a cells assessed as cell viability after 72 hrs by MTT assay
Cytotoxicity against mouse Neuro2a cells assessed as cell viability after 72 hrs by MTT assay
[PMID: 28152427]
NALM-6 EC50
1.4 μM
Compound: STS
Antiproliferative activity against human NALM6 cells after 72 hrs by CellTiter-Glo luminescent cell viability assay
Antiproliferative activity against human NALM6 cells after 72 hrs by CellTiter-Glo luminescent cell viability assay
[PMID: 30840453]
NCI-H460 IC50
> 0.1 μM
Compound: Staurosporine
Antiproliferative activity against human NCI-H460 cells assessed as inhibition of cell viability measured after 72 hrs by colorimetric MTS viability assay
Antiproliferative activity against human NCI-H460 cells assessed as inhibition of cell viability measured after 72 hrs by colorimetric MTS viability assay
[PMID: 34352711]
NCI-H460 IC50
0.0597 μM
Compound: Staurosporine
Antiproliferative activity against human NCI-H460 cells assessed as inhibition of cell proliferation measured after 72 hrs by by real time imaging analysis
Antiproliferative activity against human NCI-H460 cells assessed as inhibition of cell proliferation measured after 72 hrs by by real time imaging analysis
[PMID: 33248847]
NCI-H460 IC50
0.06 μM
Compound: STS
Antiproliferative activity against human NCI-H460 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell imaging assay
Antiproliferative activity against human NCI-H460 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell imaging assay
[PMID: 32832030]
NCI-H460 GI50
3.6 μM
Compound: Staurosporine
Cytotoxicity against human H460 cells after 48 hrs by SRB assay
Cytotoxicity against human H460 cells after 48 hrs by SRB assay
[PMID: 21513294]
NIH3T3 EC50
0.008 μM
Compound: Staurosporine
Cytotoxicity against mouse NIH3T3 cells assessed as reduction in cell viability measured after 72 hrs by SRB assay
Cytotoxicity against mouse NIH3T3 cells assessed as reduction in cell viability measured after 72 hrs by SRB assay
[PMID: 33049606]
NIH3T3 IC50
0.008 μM
Compound: ST
Cytotoxicity against mouse NIH3T3 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
Cytotoxicity against mouse NIH3T3 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
[PMID: 32422522]
NIH3T3 EC50
0.008 μM
Compound: STS
Cytotoxicity against mouse NIH/3T3 cells assessed as reduction in cell viability after 96 hrs by SRB assay
Cytotoxicity against mouse NIH/3T3 cells assessed as reduction in cell viability after 96 hrs by SRB assay
[PMID: 30840925]
NIH3T3 EC50
0.008 μM
Compound: STS
Cytotoxicity against mouse NIH/3T3 cells after 96 hrs by SRB assay
Cytotoxicity against mouse NIH/3T3 cells after 96 hrs by SRB assay
[PMID: 29197730]
NIH3T3 IC50
0.2 μM
Compound: STP
Cytotoxicity against mouse NIH/3T3 cells after 96 hrs by SRB assay
Cytotoxicity against mouse NIH/3T3 cells after 96 hrs by SRB assay
[PMID: 24361521]
NIH3T3 IC50
140.12 μM
Compound: Staurosporine
Cytotoxicity against mouse NIH/3T3 cells after 24 hrs by MTT assay
Cytotoxicity against mouse NIH/3T3 cells after 24 hrs by MTT assay
[PMID: 24286761]
PBMC IC50
0.0002 μM
Compound: Staurosporine
Cytotoxicity against human PBMC cells assessed as inhibition of cell proliferation measured after 72 hrs by radioactive cell proliferation assay
Cytotoxicity against human PBMC cells assessed as inhibition of cell proliferation measured after 72 hrs by radioactive cell proliferation assay
[PMID: 33248847]
PBMC IC50
0.016 μM
Compound: staurosporine
Inhibition of IL2 production in PHA-stimulated human PBMC after 24 hrs by ELISA
Inhibition of IL2 production in PHA-stimulated human PBMC after 24 hrs by ELISA
[PMID: 18823784]
PBMC IC50
0.016 μM
Compound: 1
Suppression of IL2 production in human PBMC after 24 hrs by ELISA
Suppression of IL2 production in human PBMC after 24 hrs by ELISA
[PMID: 18585046]
PC-3 IC50
0.017 μM
Compound: Staurosporine
Cytotoxicity against human PC3 cells by sulforhodamine B assay
Cytotoxicity against human PC3 cells by sulforhodamine B assay
[PMID: 29389122]
PC-3 IC50
0.031 μM
Compound: staurosporine
Cytotoxicity against human PC3 cells after 48 hrs by MTT assay
Cytotoxicity against human PC3 cells after 48 hrs by MTT assay
[PMID: 25825934]
PC-3 IC50
0.039 μM
Compound: STU
Cytotoxicity against human PC3 cells after 72 hrs by SRB assay
Cytotoxicity against human PC3 cells after 72 hrs by SRB assay
[PMID: 29558119]
PC-3 IC50
4.91 μM
Compound: Staurosporine
Antiproliferative activity against human PC3 cells measured after 72 hrs under normoxic condition by MTT assay
Antiproliferative activity against human PC3 cells measured after 72 hrs under normoxic condition by MTT assay
[PMID: 31794211]
PC-3 IC50
5.92 μM
Compound: Staurosporine
Antiproliferative activity against human PC3 cells measured after 72 hrs under CoCl2-induced hypoxic condition by MTT assay
Antiproliferative activity against human PC3 cells measured after 72 hrs under CoCl2-induced hypoxic condition by MTT assay
[PMID: 31794211]
RBL-2H3 IC50
0.2 μM
Compound: Staurosporine
Anti-allergic activity in rat RBL2H3 cells assessed as reduction in mouse anti-DNP IgE-induced IL-4 level preincubated for 15 mins followed by mouse anti-DNP IgE-stimulation and measured after 3 hrs by ELISA
Anti-allergic activity in rat RBL2H3 cells assessed as reduction in mouse anti-DNP IgE-induced IL-4 level preincubated for 15 mins followed by mouse anti-DNP IgE-stimulation and measured after 3 hrs by ELISA
[PMID: 30711393]
RBL-2H3 IC50
0.3 μM
Compound: Staurosporine
Anti-allergic activity in rat RBL2H3 cells assessed as reduction in mouse anti-DNP IgE-induced TNF-alpha level preincubated for 15 mins followed by mouse anti-DNP IgE-stimulation and measured after 3 hrs by ELISA
Anti-allergic activity in rat RBL2H3 cells assessed as reduction in mouse anti-DNP IgE-induced TNF-alpha level preincubated for 15 mins followed by mouse anti-DNP IgE-stimulation and measured after 3 hrs by ELISA
[PMID: 30711393]
RBL-2H3 IC50
0.3 μM
Compound: Staurosporine
Inhibition of PKC in rat RBL2H3 cells assessed as inhibition of mouse anti-DNP IgE-stimulated beta-hexosaminidase release preincubated for 15 mins followed by mouse anti-DNP IgE stimulation and measured after 3 hrs by 4-nitropheny1-2-acetamide-2-deoxy-bet
Inhibition of PKC in rat RBL2H3 cells assessed as inhibition of mouse anti-DNP IgE-stimulated beta-hexosaminidase release preincubated for 15 mins followed by mouse anti-DNP IgE stimulation and measured after 3 hrs by 4-nitropheny1-2-acetamide-2-deoxy-bet
[PMID: 31879206]
RBL-2H3 IC50
0.3 μM
Compound: Staurosporine
Anti-allergic activity in rat RBL2H3 cells assessed as reduction in mouse anti-DNP IgE-induced beta-hexosaminidase release preincubated for 15 mins followed by mouse anti-DNP IgE-stimulation and measured after 3 hrs by p-nitrophenyl-2-acetamide-2-deoxy-be
Anti-allergic activity in rat RBL2H3 cells assessed as reduction in mouse anti-DNP IgE-induced beta-hexosaminidase release preincubated for 15 mins followed by mouse anti-DNP IgE-stimulation and measured after 3 hrs by p-nitrophenyl-2-acetamide-2-deoxy-be
[PMID: 30711393]
RBL-2H3 IC50
0.5 μM
Compound: Staurosporine
Inhibition of PKC in rat RBL2H3 cells assessed as inhibition of anti-DNP IgE-stimulated TNFalpha release preincubated for 15 mins followed by mouse anti-DNP IgE stimulation and measured after 3 hrs by ELISA
Inhibition of PKC in rat RBL2H3 cells assessed as inhibition of anti-DNP IgE-stimulated TNFalpha release preincubated for 15 mins followed by mouse anti-DNP IgE stimulation and measured after 3 hrs by ELISA
[PMID: 31879206]
RBL-2H3 IC50
0.7 μM
Compound: Staurosporine
Anti-allergic activity in rat RBL2H3 cells assessed as reduction in calcium ionophore-induced IL-4 level preincubated for 15 mins followed by calcium ionophore stimulation and measured after 3 hrs by ELISA
Anti-allergic activity in rat RBL2H3 cells assessed as reduction in calcium ionophore-induced IL-4 level preincubated for 15 mins followed by calcium ionophore stimulation and measured after 3 hrs by ELISA
[PMID: 30711393]
RBL-2H3 IC50
0.8 μM
Compound: Staurosporine
Inhibition of PKC in rat RBL2H3 cells assessed as inhibition of ionomycin-stimulated beta-hexosaminidase release preincubated for 15 mins followed by ionomycin stimulation and measured after 3 hrs by 4-nitropheny1-2-acetamide-2-deoxy-beta-glucopyranoside
Inhibition of PKC in rat RBL2H3 cells assessed as inhibition of ionomycin-stimulated beta-hexosaminidase release preincubated for 15 mins followed by ionomycin stimulation and measured after 3 hrs by 4-nitropheny1-2-acetamide-2-deoxy-beta-glucopyranoside
[PMID: 31879206]
RBL-2H3 IC50
1 μM
Compound: Staurosporine
Inhibition of PKC in rat RBL2H3 cells assessed as inhibition of ionomycin-stimulated TNFalpha release preincubated for 15 mins followed by ionomycin stimulation and measured after 3 hrs by ELISA
Inhibition of PKC in rat RBL2H3 cells assessed as inhibition of ionomycin-stimulated TNFalpha release preincubated for 15 mins followed by ionomycin stimulation and measured after 3 hrs by ELISA
[PMID: 31879206]
RBL-2H3 IC50
1 μM
Compound: Staurosporine
Anti-allergic activity in rat RBL2H3 cells assessed as reduction in calcium ionophore-induced TNF-alpha level preincubated for 15 mins followed by calcium ionophore stimulation and measured after 3 hrs by ELISA
Anti-allergic activity in rat RBL2H3 cells assessed as reduction in calcium ionophore-induced TNF-alpha level preincubated for 15 mins followed by calcium ionophore stimulation and measured after 3 hrs by ELISA
[PMID: 30711393]
RBL-2H3 IC50
1 μM
Compound: Staurosporine
Anti-allergic activity in rat RBL2H3 cells assessed as reduction in calcium ionophore-induced beta-hexosaminidase release preincubated for 15 mins followed by calcium ionophore-stimulation and measured after 3 hrs by p-nitrophenyl-2-acetamide-2-deoxy-beta
Anti-allergic activity in rat RBL2H3 cells assessed as reduction in calcium ionophore-induced beta-hexosaminidase release preincubated for 15 mins followed by calcium ionophore-stimulation and measured after 3 hrs by p-nitrophenyl-2-acetamide-2-deoxy-beta
[PMID: 30711393]
Rec1 IC50
0.0255 μM
Compound: Staurosporine
Cytotoxicity against human REC1 cells assessed as inhibition of cell viability measured after 72 hrs by real-time IncuCyte proliferation analysis
Cytotoxicity against human REC1 cells assessed as inhibition of cell viability measured after 72 hrs by real-time IncuCyte proliferation analysis
[PMID: 34352711]
Sf21 IC50
0.002 μM
Compound: Staurosporine
Inhibition of human recombinant JAK2 expressed in Sf21 cells assessed as reduction in Ulight-CAGAGAIETDKEYYTVKD phosphorylation pre-incubated before substrate addition and measured after 60 mins by LANCE detection method
Inhibition of human recombinant JAK2 expressed in Sf21 cells assessed as reduction in Ulight-CAGAGAIETDKEYYTVKD phosphorylation pre-incubated before substrate addition and measured after 60 mins by LANCE detection method
[PMID: 27137359]
Sf21 IC50
0.027 μM
Compound: staurosporine
Inhibition of human CHK2 kinase expressed in insect Sf21 cells using phospho-CREBtide as substrate at 30 uM
Inhibition of human CHK2 kinase expressed in insect Sf21 cells using phospho-CREBtide as substrate at 30 uM
[PMID: 21334796]
Sf21 IC50
0.039 μM
Compound: staurosporine
Inhibition of human recombinant IKK-alpha expressed in insect Sf21 cells using phospho-Ulight-IkappaB-alpha as substrate at 30 uM
Inhibition of human recombinant IKK-alpha expressed in insect Sf21 cells using phospho-Ulight-IkappaB-alpha as substrate at 30 uM
[PMID: 21334796]
Sf21 IC50
0.49 μM
Compound: staurosporine
Inhibition of human recombinant IKK-beta expressed in insect Sf21 cells using phospho-Ulight-IkappaB-alpha as substrate at 30 uM
Inhibition of human recombinant IKK-beta expressed in insect Sf21 cells using phospho-Ulight-IkappaB-alpha as substrate at 30 uM
[PMID: 21334796]
Sf21 IC50
1325 nM
Compound: Staurosporine
Inhibition of IGF-induced autophosphosphorylation of GST-tagged human IGF1R expressed in baculovirus-SF21 cell system preincubated for 5 mins by time resolved-fluorescent assay
Inhibition of IGF-induced autophosphosphorylation of GST-tagged human IGF1R expressed in baculovirus-SF21 cell system preincubated for 5 mins by time resolved-fluorescent assay
[PMID: 21441024]
Sf21 IC50
1533 nM
Compound: Staurosporine
Inhibition of IGF-induced autophosphosphorylation of GST-tagged human IGF1R expressed in baculovirus-SF21 cell system preincubated for 30 mins by time resolved-fluorescent assay
Inhibition of IGF-induced autophosphosphorylation of GST-tagged human IGF1R expressed in baculovirus-SF21 cell system preincubated for 30 mins by time resolved-fluorescent assay
[PMID: 21441024]
Sf21 IC50
1646 nM
Compound: Staurosporine
Inhibition of IGF-induced autophosphosphorylation of GST-tagged human IGF1R expressed in baculovirus-SF21 cell system preincubated for 60 mins by time resolved-fluorescent assay
Inhibition of IGF-induced autophosphosphorylation of GST-tagged human IGF1R expressed in baculovirus-SF21 cell system preincubated for 60 mins by time resolved-fluorescent assay
[PMID: 21441024]
Sf21 IC50
1701 nM
Compound: Staurosporine
Inhibition of IGF-induced autophosphosphorylation of GST-tagged human IGF1R expressed in baculovirus-SF21 cell system preincubated for 10 mins by time resolved-fluorescent assay
Inhibition of IGF-induced autophosphosphorylation of GST-tagged human IGF1R expressed in baculovirus-SF21 cell system preincubated for 10 mins by time resolved-fluorescent assay
[PMID: 21441024]
SF-268 GI50
0.044 μM
Compound: Staurosporine
Cytotoxicity against human SF268 cells after 48 hrs by SRB assay
Cytotoxicity against human SF268 cells after 48 hrs by SRB assay
[PMID: 21513294]
Sf9 IC50
> 18.5 μM
Compound: Staurosporine
Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay
Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay
[PMID: 24786585]
Sf9 IC50
0.0039 μM
Compound: Staurosporine
Inhibition of N-terminal His-tagged recombinant human AXL (473 to end amino acids) expressed by baculovirus in Sf9 cells using axltide substrate and ATP by ADP-Glo luminescence assay
Inhibition of N-terminal His-tagged recombinant human AXL (473 to end amino acids) expressed by baculovirus in Sf9 cells using axltide substrate and ATP by ADP-Glo luminescence assay
[PMID: 30340900]
Sf9 IC50
0.005 μM
Compound: Staurosporine
Inhibition of human Fyn expressed in Sf9 cells after 1 min by ELISA in presence of 1 umol/L ATP
Inhibition of human Fyn expressed in Sf9 cells after 1 min by ELISA in presence of 1 umol/L ATP
[PMID: 17315853]
Sf9 IC50
0.015 μM
Compound: Staurosporine
Inhibition of human Fyn expressed in Sf9 cells after 20 mins by ELISA in presence of 1 umol/L ATP
Inhibition of human Fyn expressed in Sf9 cells after 20 mins by ELISA in presence of 1 umol/L ATP
[PMID: 17315853]
Sf9 IC50
0.036 μM
Compound: Staurosporine
Inhibition of human Fyn expressed in Sf9 cells after 1 min by ELISA in presence of 10 umol/L ATP
Inhibition of human Fyn expressed in Sf9 cells after 1 min by ELISA in presence of 10 umol/L ATP
[PMID: 17315853]
Sf9 IC50
0.083 μM
Compound: Staurosporine
Inhibition of human Fyn expressed in Sf9 cells after 20 mins by ELISA in presence of 10 umol/L ATP
Inhibition of human Fyn expressed in Sf9 cells after 20 mins by ELISA in presence of 10 umol/L ATP
[PMID: 17315853]
Sf9 IC50
0.27 μM
Compound: Staurosporine
Inhibition of human Fyn expressed in Sf9 cells after 1 min by ELISA in presence of 100 umol/L ATP
Inhibition of human Fyn expressed in Sf9 cells after 1 min by ELISA in presence of 100 umol/L ATP
[PMID: 17315853]
Sf9 IC50
0.51 μM
Compound: Staurosporine
Inhibition of human Fyn expressed in Sf9 cells after 20 mins by ELISA in presence of 100 umol/L ATP
Inhibition of human Fyn expressed in Sf9 cells after 20 mins by ELISA in presence of 100 umol/L ATP
[PMID: 17315853]
Sf9 IC50
1.2 nM
Compound: Staurosporine
Inhibition of N-terminal GST tagged recombinant full-length human CHK1 expressed in baculovirus Sf9 insect cells after 10 mins by luminescent ADP-Glo assay
Inhibition of N-terminal GST tagged recombinant full-length human CHK1 expressed in baculovirus Sf9 insect cells after 10 mins by luminescent ADP-Glo assay
[PMID: 27089211]
Sf9 IC50
2.3 μM
Compound: staurosporine
Inhibition of human recombinant GST-fused NIK expressed in Sf9 cells after 60 mins by radiometric protein kinase assay
Inhibition of human recombinant GST-fused NIK expressed in Sf9 cells after 60 mins by radiometric protein kinase assay
[PMID: 20580552]
ST486 IC50
0.007 μM
Compound: Staurosporine
Antiproliferative activity against human ST486 cells after 48 to 72 hrs by MTT assay
Antiproliferative activity against human ST486 cells after 48 to 72 hrs by MTT assay
[PMID: 22182929]
SUP-B15 EC50
0.55 μM
Compound: STS
Antiproliferative activity against human SUP-B15 cells after 72 hrs by CellTiter-Glo luminescent cell viability assay
Antiproliferative activity against human SUP-B15 cells after 72 hrs by CellTiter-Glo luminescent cell viability assay
[PMID: 30840453]
SW 1116 EC50
24.92 μg/mL
Compound: Staurosporine
Antiproliferative activity against human SW1116 cells after 48 hrs by MTT assay
Antiproliferative activity against human SW1116 cells after 48 hrs by MTT assay
[PMID: 21889345]
SW 1116 IC50
4.18 μM
Compound: Staurosporine
Inhibition of telomerase in human SW1116 cells after 24 hrs by TRAP-PCR-ELISA assay
Inhibition of telomerase in human SW1116 cells after 24 hrs by TRAP-PCR-ELISA assay
[PMID: 24286761]
SW 1116 IC50
4.95 μM
Compound: Staurosporine
Antiproliferative activity against human SW1116 cells after 48 hrs by MTT method
Antiproliferative activity against human SW1116 cells after 48 hrs by MTT method
[PMID: 23018096]
SW 1116 IC50
8.32 μM
Compound: Staurosporine
Inhibition of telomerase in human SW1116 cells after 24 hrs by TRAP-PCR-ELISA assay
Inhibition of telomerase in human SW1116 cells after 24 hrs by TRAP-PCR-ELISA assay
[PMID: 21962523]
SW-1736 EC50
0.2 μM
Compound: STS
Cytotoxicity against human SW1736 cells assessed as reduction in cell viability after 96 hrs by SRB assay
Cytotoxicity against human SW1736 cells assessed as reduction in cell viability after 96 hrs by SRB assay
[PMID: 30840925]
SW480 IC50
< 0.1 μM
Compound: Staurosporine
Antiproliferative activity against human SW480 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
Antiproliferative activity against human SW480 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
[PMID: 31740249]
T47D IC50
11.7 μM
Compound: Staurosporine
Cytotoxicity against human T47D cells assessed as reduction in cell viability after 3 hrs by MTT assay
Cytotoxicity against human T47D cells assessed as reduction in cell viability after 3 hrs by MTT assay
[PMID: 33962153]
T47D IC50
4.52 μM
Compound: Staurosporine
Cytotoxicity against human T47D cells assessed as inhibition of cell proliferation measured after 72 hrs by SRB assay
Cytotoxicity against human T47D cells assessed as inhibition of cell proliferation measured after 72 hrs by SRB assay
[PMID: 32044580]
TERT-RPE1 IC50
0.0055 μM
Compound: Staurosporine
Cytotoxicity against human TERT-RPE1 cells assessed as inhibition of cell proliferation measured after 72 hrs by real time imaging analysis
Cytotoxicity against human TERT-RPE1 cells assessed as inhibition of cell proliferation measured after 72 hrs by real time imaging analysis
[PMID: 33248847]
UoC-B1 EC50
2 μM
Compound: STS
Antiproliferative activity against human UOCB1 cells after 72 hrs by CellTiter-Glo luminescent cell viability assay
Antiproliferative activity against human UOCB1 cells after 72 hrs by CellTiter-Glo luminescent cell viability assay
[PMID: 30840453]
Vero IC50
0.0024 μM
Compound: Staurosporine
Cytotoxicity against African green monkey Vero cells after 2 days by CellTiter-Glo luminescent cell viability assay
Cytotoxicity against African green monkey Vero cells after 2 days by CellTiter-Glo luminescent cell viability assay
[PMID: 28993106]
Vero IC50
0.028 μM
Compound: Staurosporine
Cytotoxicity against African green monkey Vero cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Cytotoxicity against African green monkey Vero cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
[PMID: 30743094]
WI-38 IC50
24.41 μM
Compound: Staurosporine
Cytotoxicity against human WI-38 cells assessed as cell viability measured by MTT assay
Cytotoxicity against human WI-38 cells assessed as cell viability measured by MTT assay
[PMID: 34246754]
Z-138 IC50
0.0067 μM
Compound: Staurosporine
Antiproliferative activity against human Z138 cells assessed as inhibition of cell proliferation measured after 72 hrs by by real time imaging analysis
Antiproliferative activity against human Z138 cells assessed as inhibition of cell proliferation measured after 72 hrs by by real time imaging analysis
[PMID: 33248847]
Z-138 IC50
0.02 μM
Compound: STS
Antiproliferative activity against human Z138 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell imaging assay
Antiproliferative activity against human Z138 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell imaging assay
[PMID: 32832030]
Z-138 IC50
0.0418 μM
Compound: Staurosporine
Antiproliferative activity against human Z138 cells assessed as inhibition of cell viability measured after 72 hrs by real-time IncuCyte proliferation analysis
Antiproliferative activity against human Z138 cells assessed as inhibition of cell viability measured after 72 hrs by real-time IncuCyte proliferation analysis
[PMID: 34352711]
In Vitro

Staurosporine, widely used as a protein kinase C (PKC) inhibitor with a broad spectrum of activity, is an alkaloid which can be isolated from the culture broth of Streptomyces staurospores. MC3T3E-1 osteoblasts, expose to Staurosporine (100 nM) for 12 h, release an amount of LDH (12.4±3.1%) that is similar to that release by the control cells(10.0±2.4%), indicating the relative absence of lytic death, which occurs in necrosis. In addition, treatment with Staurosporine (100 nM) results in morphological changes, characteristic of apoptosis: a brightblue fluorescent condensed nuclei seen through a fluorescence microscope after Hoechst 33258-staining, and a reduction of cell volume[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Solvent & Solubility
In Vitro: 

DMSO : 62.5 mg/mL (133.97 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 2.1435 mL 10.7174 mL 21.4348 mL
5 mM 0.4287 mL 2.1435 mL 4.2870 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months. When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

  • Protocol 1

    Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

    Solubility: ≥ 2.08 mg/mL (4.46 mM); Clear solution

    This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).

    Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

    Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
  • Protocol 2

    Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

    Solubility: 2.08 mg/mL (4.46 mM); Suspended solution; Need ultrasonic

    This protocol yields a suspended solution of 2.08 mg/mL. Suspended solution can be used for oral and intraperitoneal injection.

    Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

    Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.

For the following dissolution methods, please prepare the working solution directly. It is recommended to prepare fresh solutions and use them promptly within a short period of time.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

  • Protocol 1

    Add each solvent one by one:  0.5% CMC-Na/saline water

    Solubility: 3.33 mg/mL (7.14 mM); Suspension solution; Need ultrasonic

Purity & Documentation
References

You might also be interested by the following products:



Cat#
Description
Cond.
Price Bef. VAT
T2130-25mg
 25mg 
T11631-10mg
 10mg